Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.75 |
| ▸ | ECE1 | P42892 | 12/20 | 0.72 |
| ▸ | CTSC | P53634 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valyltryptophan SCHEMBL150532 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL30821963 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL30821897 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL150533 | 1.00 | ACE (0.75) | ACEECE1CTSCALOX15 | |
| SCHEMBL30051305 | 0.98 | ACE (0.72) | ACEECE1CTSCALOX15 | |
| SCHEMBL30051858 | 0.96 | ACE (0.69) | ACEECE1CTSCALOX15 | |
| SCHEMBL30051553 | 0.95 | ACE (0.68) | ACEECE1CTSCALOX15 | |
| SCHEMBL30052892 | 0.94 | ACE (0.67) | ACEECE1CTSC | |
| Hydrochloric Acid SCHEMBL11229707 | 0.94 | ACE (0.67) | ACEECE1CTSCALOX15 | |
| Valyltryptophan SCHEMBL30641543 | 0.94 | ACE (0.67) | ACEECE1CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3448409-B1 | TREATMENT OF LIVER, BILIARY TRACT AND PANCREATIC DISORDERS WITH DEFENSINS | DEFENSIN THERAPEUTICS APS (DK) | 2025-12-03 | — | — | EP | claimed |
| CN-119074627-B | Cell active peptide composition with anti-allergic and anti-reddening effects, preparation method and medical application thereof | 珠海金肽生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120019803-A | Repairing anti-wrinkle black eye removing eye cream and preparation method thereof | 浙江寿仙谷健康科技有限公司 | 2025-05-20 | — | — | CN | claimed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | claimed |
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119708119-A | Process for the preparation of dipeptide-2 | 攀枝花学院 | 2025-03-28 | — | — | CN | claimed |
| CN-119613485-A | Preparation method of dipeptide-2 | 中原食品实验室 | 2025-03-14 | — | — | CN | claimed |
| CN-119587404-A | Eye care composition and eye care solution | 广州澳莱娜生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119302866-A | Composite polypeptide tightening essence and preparation method thereof | 广东暨肽基因生物工程有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119280134-A | Peony collagen polypeptide composition for tightening and anti-wrinkle and preparation method thereof | 广州名门闺秀生物科技有限责任公司 | 2025-01-10 | — | — | CN | claimed |
| CN-114767567-A | Water-soluble oligopeptide composition for resisting skin aging and static wrinkles | 四川肽美生物科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-111700853-B | Cosmetic composition with anti-allergy repairing effect and application thereof | 广州澳希亚实业有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114642607-A | Moisturizing, moisturizing and long-acting skin care double-bottle essence and preparation and use methods thereof | 上海康美国际生化有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-114634547-A | Dipeptide-2 synthesis process | 山东济肽生物科技有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-114588084-A | Black eye removing, relieving and wrinkle resisting composition, eye mask and preparation method of eye mask | 广州市涵美化妆品有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-114557905-A | Endogenous cell regulation system and application thereof | 云南美颜美龄生物科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-109700687-B | Flexible liposome cosmetic containing active polypeptide and preparation method thereof | 深圳高尚科美生物科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114306128-A | Anti-aging and anti-firming composition and preparation method thereof | 广州盛妍精细化工有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114288201-A | Composition for removing under-eye puffiness and fading black eye circles and preparation method and application thereof | 广东巴松那生物科技有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-114028259-A | Eye cream and preparation method thereof | 广东长昊药业股份有限公司 | 2022-02-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | ACE 2638/4885ECE1 3305/4885CTSC 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.